Aquestive Therapeutics In... (AQST)
3.04
-0.07 (-2.25%)
At close: Jan 14, 2025, 3:59 PM
3.06
0.49%
After-hours Jan 14, 2025, 04:07 PM EST
Price Reaction to Earnings Reports
This table provides an overview of how a stock's price historically reacted around earnings reports. It displays key metrics like price changes over specific timeframes and Relative Strength Index (RSI).
| Report Date | -3 Days | -2 Days | -1 Day | Open | High | Low | Close | +1 Day | +2 Days | +3 Days | +1 Week | -1 Week | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov 4, 2024
(Q3) AMC Q3 2024 | 5.49 | 5.52 | 5.15 | 5.00 | 5.12 | 4.62 | 4.76 | 5.07 | 5.08 | 5.46 | 4.99 | 5.66 | ||
IV: 1.08 RSI: 50 AQST % | -2.66% | 0.55% | 0.55% | -2.91%
| -0.58%
| -10.29%
| -7.57%
| 6.51% | 0.20% | 7.48% | -1.58% | 3.10% | ||
Aug 6, 2024
(Q2) AMC Q2 2024 | 3.44 | 3.29 | 3.40 | 3.64 | 3.72 | 3.41 | 3.43 | 3.29 | 3.43 | 3.40 | 3.86 | 3.84 | ||
IV: 1.34 RSI: 55 AQST % | -4.18% | -4.36% | -4.36% | 7.06%
| 9.41%
| 0.29%
| 0.88%
| -4.08% | 4.26% | -0.87% | -1.53% | 1.05% | ||
May 7, 2024
(Q1) AMC Q1 2024 | 3.52 | 3.50 | 3.38 | 3.18 | 3.23 | 2.91 | 3.09 | 3.29 | 3.09 | 3.27 | 3.22 | 3.37 | ||
IV: 1.02 RSI: 39 AQST % | 7.32% | -0.57% | -0.57% | -5.92%
| -4.44%
| -13.91%
| -8.58%
| 6.47% | -6.08% | 5.83% | 0.63% | 0.30% | ||
| Daily change and RSI 14 are based on the report date for BMO releases and the following day for AMC releases. | ||||||||||||||
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options Data
- Instant access to live options data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.